Aktive Positionen von Poh Sing Ng
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Poh Sing Ng
Statistik
International
Japan | 2 |
Operativ
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
- Börse
- Insiders
- Poh Sing Ng
- Erfahrung